HALPER SADEH LLC ENCOURAGES IRHYTHM TECHNOLOGIES, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Shareholders should contact the firm immediately as there may be limited time to enforce your rights. NEW YORK , Dec. 5, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of iRhythm Technologies, Inc. (NASDAQ: IRTC) breached their fiduciary duties to shareholders.

PRNewsWire • Dec 5, 2025

Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm

NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of  iRhythm Technologies, Inc. (NASDAQ: IRTC) breached their fiduciary duties to shareholders.

GlobeNewsWire • Dec 3, 2025

iRhythm Technologies, Inc. (IRTC) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

iRhythm Technologies, Inc. (IRTC) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Seeking Alpha • Dec 3, 2025

Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of iRhythm Technologies, Inc. – IRTC

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces an investigation of potential breaches of fiduciary duties by the directors and officers of iRhythm Technologies, Inc. (NASDAQ: IRTC). If you currently own shares of iRhythm stock, please visit the firm's website at https://rosenlegal.com/submit-form/?case_id=22399 for more information. You may also contact Phillip Kim of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected]. Why Rosen.

Business Wire • Nov 13, 2025

iRhythm Technologies Announces Publication of Large-Scale Study in Heart Rhythm and New Data Presented at AHA Scientific Sessions 2025

New Heart Rhythm Journal publication and AHA 2025 data reinforce Zio LTCM clinical value and real-world evidence supporting proactive cardiac monitoring.

GlobeNewsWire • Nov 11, 2025

iRhythm: The Heart Monitor Maker Whose Stock Keeps Beating

iRhythm Technologies stock has doubled this year.

Barrons • Nov 5, 2025

iRhythm Technologies to Participate in Upcoming Investor Conferences

SAN FRANCISCO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that its management team is scheduled to present at the following investor conferences.

GlobeNewsWire • Nov 4, 2025

iRhythm Well-Positioned For 2026 After Upbeat Results And Raised Outlook

iRhythm Technologies Inc. (NASDAQ:IRTC) reported a third-quarter loss of 6 cents per share on Thursday, better than analysts' expectation of a 31-cent loss.

Benzinga • Oct 31, 2025

iRhythm Technologies, Inc. (IRTC) Q3 2025 Earnings Call Transcript

iRhythm Technologies, Inc. ( IRTC ) Q3 2025 Earnings Call October 30, 2025 4:30 PM EDT Company Participants Stephanie Zhadkevich - Director of Investor Relations Quentin Blackford - President, CEO & Director Daniel Wilson - CFO & Principal Financial Officer Conference Call Participants Nathan Treybeck - Wells Fargo Securities, LLC, Research Division Richard Newitter - Truist Securities, Inc., Research Division David Saxon - Needham & Company, LLC, Research Division Sam Eiber - BTIG, LLC, Research Division Suraj Kalia - Oppenheimer & Co. Inc., Research Division David Rescott - Robert W. Baird & Co. Incorporated, Research Division Stephanie Piazzola - BofA Securities, Research Division Max Kruszeski - William Blair & Company L.L.C.

Seeking Alpha • Oct 31, 2025

iRhythm Technologies Announces Third Quarter 2025 Financial Results

SAN FRANCISCO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months ended September 30, 2025.

GlobeNewsWire • Oct 30, 2025